Contact A Counsellor

counsellor button


teen suicide icon


panic anxiety icon

panic anxiety icon

#MindfulMondays with Miss SA

teen suicide icon


Research on Depression in the Workplace.

For more information please click here



email subscribers list

To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here


Mental Health Matters Journal for Psychiatrists & GP's

MHM Volume 8 Issue1

Click here for more info


journalists crew making newspaper

If you are a journalist writing a story contact Kayla on 011 234 4837  media@anxiety.org.za


MySchool Facebook banner Nov

It’s the small things that make a BIG difference. Sign up for the “My School | My Village | My Planet” Card and start making a difference to Mental Health in South Africa today.

Click Here


cope with cancer book

Literacy is a luxury that many of us take for granted. That is why SADAG created SPEAKING BOOKS and revolutionized the way healthcare information is delivered to low literacy communities.

The customizable 16-page book, read by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood by everyone across the world.

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 100+ titles, such as TB, Malaria, Polio, Vaccines for over 45 countries.

suicide speaking book

Electroconvulsive therapy (ECT) remains one of the most effective treatments we have to treat depression. Acute response rates for ECT are consistently higher than response rates generally reported in clinical trials for antidepressant medications. This observation is doubly impressive knowing that patients who today receive ECT for an index episode of depression typically have failed 2 or more antidepressant medication trials.

The bipolar pharmacopoeia has steadily increased over the past 10 years. The US Food and Drug Administration (FDA) has approved 10 treatments for mania, 4 treatments for the maintenance phase of bipolar disorder, and 2 for bipolar depression. With these substantial clinical advances, it is often forgotten how effective ECT is for bipolar depression, depression with a switch into mania (ECT treatment through the mania), refractory mania, and maintenance ECT for bipolar disorder. Although it would be difficult to study with a controlled comparative design, many clinicians think that ECT is still the best mood stabilizer we have to date. Given the need for anesthesia and the potential for cognitive deficits as a side effect, ECT for bipolar depression, as with unipolar depression, has been viewed less as first-line agent and thus reserved for refractory cases.

However, ECT may be the treatment of choice for bipolar mania or depression in pregnancy to avoid potential teratogenicity related to pharmacotherapy. In addition, for bipolar patients with a compromised nutritional status who acutely become catatonic or severely depressed, and the delay of several weeks for antidepressant response is not an option, ECT would be a first-line agent. For a review of these data, see Bonds and colleagues.


Our Sponsors

Our Partners